Journal of Diabetes and Its Complications
Volume 19, Issue 1 , Pages 47-53 , January 2005

Effectiveness of Semmes–Weinstein monofilament examination for diabetic peripheral neuropathy screening

Received 28 July 2003 ,Revised 12 December 2003 ,Accepted 18 December 2003.

References 

  1. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabetic Medicine. 2002;19:377–384
  2. Abouaesha F, Van Schie CH, Griffiths GD, Young RJ, Boulton AJ. Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care. 2001;24:1270–1274
  3. American Diabetes Association . Clinical practice recommendations 1996. Diabetic neuropathy. Diabetes Care. 1996;19(Suppl. 1):S67–S71
  4. Cheng WY, Jiang YD, Chuang LM, Huang CN, Heng LT, Wu HP, et al. Quantitative sensory testing and risk factors of diabetic sensory neuropathy. Journal of Neurology. 1999;246:394–398
  5. Dimitrakoudis D, Bril V. Comparison of sensory testing on different toe surfaces: implications for neuropathy screening. Neurology. 2002;59:611–613
  6. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology. 1997;49:229–239
  7. Dyck PJ, Dyck PJ, Larson TS, O'Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor group. Diabetes Care. 2000;23:510–517
  8. Ewing DJ, Borsey DQ, Bellavere F, Clarke BF. Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia. 1981;21:18–24
  9. Hanson PH, Schumacker P, Debugne TH, Clerin M. Evaluation of somatic and autonomic small fibers neuropathy in diabetes. American Journal of Physical Medicine and Rehabilitation. 1992;71:44–47
  10. Hotta N, Sugiura K, Tsuchida I, Sano T, Koh N, Matsumae H, et al. Use of the C64 quantitative tuning fork and the effect of niceritol in diabetic neuropathy. Clinical Therapeutics. 1994;16:1007–1015
  11. Japanese Study Group on Diabetic Neuropathy . Simplified diagnostic criteria for diabetic polyneuropathy. Peripheral Nerve. 2001;12:225–227
  12. Jirkovska A, Boucek P, Woskova V, Bartos V, Skibova J. Identification of patients at risk for diabetic foot: a comparison of standardized noninvasive testing with routine practice at community diabetes clinics. Journal of Diabetes and Its Complications. 2001;15:63–68
  13. Kahn R. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Quantitative sensory testing. Diabetes Care. 1992;15:1092–1094
  14. Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ. Semmes–Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Research and Clinical Practice. 1991;13:63–67
  15. Lunetta M, Le Moli R, Grasso G, Sangiorgio L. A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Research and Clinical Practice. 1998;39:165–172
  16. Martina IS, van Koningsveld R, Schmitz PI, van der Meche FG, van Doorn PA. Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group. Journal of Neurology, Neurosurgery, Psychiatry. 1998;65:743–747
  17. McGill M, Molyneaux L, Spencer R, Heng LF, Yue DK. Possible sources of discrepancies in the use of the Semmes–Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care. 1999;22:598–602
  18. Nagai Y, Sugiyama Y, Abe T, Nomura G. 4-g monofilament is clinically useful for detecting diabetic peripheral neuropathy. Diabetes Care. 2001;24:183–184
  19. Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Research and Clinical Practice. 2001;54:115–128
  20. Olmos PR, Cataland S, O'Dorisio TM, Casey CA, Smead WL, Simon SR. The Semmes–Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes. The American Journal of the Medical Sciences. 1995;309:76–82
  21. Perkins BA, Bril V. Diabetic neuropathy: a review emphasizing diagnostic methods. Clinical Neurophysiology. 2003;114:1167–1175
  22. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001;24:250–256
  23. Rahman M, Griffin SJ, Rathmann W, Wareham NJ. How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures. Diabetic Medicine. 2003;20:368–374
  24. Sosenko JM, Sparling YH, Hu D, Welty T, Howard BV, Lee E, et al. Use of the Semmes–Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy. Diabetes Care. 1999;22:1715–1721
  25. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia. 1996;39:1377–1384
  26. The International Working Group on the Diabetic Foot . Practical guidelines on the management and the prevention of the diabetic foot. Based upon the International Consensus on the Diabetic Foot. 1999; Amsterdam, the Netherlands
  27. Valk GD, Grootenhuis PA, van Eijk JTM, Bouter LM, Bertelsmann FW. Methods for assessing diabetic polyneuropathy: validity and reproducibility of the measurement of sensory symptom severity and nerve function tests. Diabetes Research and Clinical Practice. 2000;47:87–95
  28. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia. 2000;43:957–973
  29. Vinik AI, Suwanwalaikorn S, Stansberry KB, Holland MT, McNitt PM, Colen LE. Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle and Nerve. 1995;18:574–584
  30. Young MJ, Boulton AJM, Macleod AF, Williams DDR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150–154
  31. Ziegler D, Gries FA, Spuller M, Lessmann F  the DiaCAN Multicenter Study Group . The epidemiology of diabetic neuropathy. Journal of Diabetes and Its Complications. 1992;6:49–57

PII: S1056-8727(03)00119-3

doi: 10.1016/j.jdiacomp.2003.12.006

Journal of Diabetes and Its Complications
Volume 19, Issue 1 , Pages 47-53 , January 2005

Article Tools

* Image Usage & Resolution